[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Alignment Healthcare, Inc. (ALHC) Form 144 notifies a proposed sale of 430,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $7,086,400 and approximately 198,031,000 shares outstanding. The shares were acquired as restricted stock units on 03/25/2025. The filing lists the approximate sale date as 09/10/2025. The filing also discloses prior sales by JEK TRUST U/A DTD 02/08/2021 totaling 895,018 shares across June–September 2025 under 10b5-1 plans and direct sale, with listed gross proceeds for each sale. The notice includes required representations about material nonpublic information and 10b5-1 plan adoption language.

Positive

• Proposed sale is limited in size, roughly 0.22% of outstanding shares, implying low immediate dilution or market impact
• Shares were acquired as RSUs, consistent with compensation-related sales rather than opportunistic insider disposition
• Prior sales executed under 10b5-1 plans, indicating preplanned, compliant selling activity

Negative

• Ongoing selling by JEK TRUST: 895,018 shares sold in the past three months, which could create downward pressure if selling continues
• Filing excerpt omits some contact/filer identifiers in the provided content, limiting attribution and context

Insights

Securities Analyst

TL;DR: Proposed sale is small relative to outstanding shares and follows RSU vesting; recent trust sales show ongoing liquidity events.

The 430,000-share proposed sale equals about 0.22% of the reported 198,031,000 shares outstanding, suggesting limited market impact. The shares were acquired as restricted stock units on 03/25/2025, indicating the sale is a disposition of compensation-related awards. Prior disposals by JEK TRUST totaling 895,018 shares in the past three months show continued selling activity, including execution under 10b5-1 plans, which supports orderly, preplanned liquidity rather than ad hoc insider selling.

Corporate Governance Expert

TL;DR: Filing follows standard insider-disclosure practices; inclusion of 10b5-1 sales suggests compliance with trading-plan protocols.

The form identifies the nature of acquisition as Restricted Stock Units and records prior 10b5-1 plan executions, which is consistent with governance best practices for insiders monetizing equity. The document includes the required attestation about absence of undisclosed material information. The filing lacks some identifying contact details in the provided excerpt, but substantive transaction details are present.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	430000	7086400.00	198031000	09/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/25/2025	Restricted Stock Units	Issuer			430000	03/25/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	09/08/2025	355018	5825845.38
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	08/11/2025	180000	2627848.00
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	07/10/2025	180000	2413795.00
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	06/16/2025	90000	1302849.00
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town and Country Road Suite 1600 Orange CA 92868	COMMON	06/11/2025	90000	1374202.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for ALHC disclose?

It notifies a proposed sale of 430,000 common shares (RSUs) through Morgan Stanley with an aggregate market value of $7,086,400 and lists an approximate sale date of 09/10/2025.

How many shares has the filing owner or related trust sold recently?

The filing reports prior sales totaling 895,018 shares during June–September 2025 executed by JEK TRUST and under 10b5-1 plans.

When were the securities being offered for sale acquired?

The securities were acquired as Restricted Stock Units on 03/25/2025, with the same date listed for acquisition/payment.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

Does the filing indicate compliance with 10b5-1 trading plans?

Yes; multiple prior sales are explicitly labeled as executed under 10b5-1 sales plans in the past three months.